CN1050748C - Production method for surface anesthesia film - Google Patents
Production method for surface anesthesia film Download PDFInfo
- Publication number
- CN1050748C CN1050748C CN93104370A CN93104370A CN1050748C CN 1050748 C CN1050748 C CN 1050748C CN 93104370 A CN93104370 A CN 93104370A CN 93104370 A CN93104370 A CN 93104370A CN 1050748 C CN1050748 C CN 1050748C
- Authority
- CN
- China
- Prior art keywords
- anesthesia
- agent
- solution
- film
- film coating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention relates to a preparing method for an anesthesia film coating agent, which is a method for preparing the film coating agent of surface anesthesia by adding an anesthesia agent, a bacteria inhibiting agent and a vasoconstriction agent. The existing anesthesia agent used in the cosmetic surgery has high medical content, poor anesthetic effect and the danger of generating a toxin function. Thus, the present invention mixes the anesthesia agent (tetracaine hydrochloride or lidocaine), chlorhexidine acetate, adrenalin, permeation enhancer (methyl ethylene glycol, dimethyl sulfoxide, menthol, etc.,) soluble high molecular film forming material (PVA, CMC, etc.,) ethanol and distilled water according to a certain proportion, and the surface film coating agent containing 1.0% to 5.0% of the anesthesia agent (the tetracaine hydrochloride or the lidocaine) is prepared. The novel anesthesia agent can rapidly penetrate the skin surface for obviously increasing the anesthesia effect, and has the functions of infection resistance and medical toxin reduction.
Description
The present invention relates to the preparation method of liniment, is a kind of adding anesthetis, the surface anesthesia film compound method of antibacterial and vasoconstrictor.
At present in beauty treatment and the clinical operation, normal employing topical anesthesia, anesthetis commonly used is 10～20% lignocaine sprays and 2～10% tetracaine solutions, because these two kinds of anesthetis all have the danger of toxigenicity effect, especially when profiling eyelid line, very easily cause corneal injury.Tetracaine solution anaesthetic effect is poor, and toxicity strengthened when content was big.Lignocaine spray anaesthetic effect is better, and dawn toxicity is big, needs special installation during preparation, and cost is higher.
In the problem and cosmetic surgery at above-mentioned anesthetis existence, the needs of topical anesthesia, the object of the present invention is to provide a kind of compound method of surface anesthesia film, be about to anesthetis, antibacterial, transdermal enhancer, vasoconstrictor, the soluble high-molecular filmogen, the second alcohol and water is mixed with surface anesthesia film in proportion, make this liniment of new preparation, be applied to very fast formation one thin film behind the skin surface, medicine energy quick penetration skin surface, strengthen anaesthetic effect, reducing toxic and side effects and can prevent local infection, is beauty treatment and the comparatively ideal anesthetis of clinical operation.
Technological means of the present invention is, (PVA, CMC etc.) are added in the distilled water with a certain amount of water soluble polymer filmogen, and fully swelling post-heating (being lower than 95 ℃) dissolves it fully, makes colloid solution (I).In addition anesthetis (tetracaine hydrochloride or lignocaine), chlorhexidine acetate, adrenalin hydrochloride, transdermal enhancer (propylene glycol, Mentholum, the inferior maple of dimethyl etc.) are dissolved in the alcoholic solution by a certain percentage, obtain medicine alcoholic solution (II).Then (II) under agitation is added among (I) of insulation about 60 ℃, mixed evenly after, be cooled to room temperature and both can.In its process for preparation, the consumption of various compositions by volume calculates, and its umber ratio is:
(I): (II)=20～30: the percentage composition W/V (%) of the various compositions in 70～80 preparation backs is: anesthetis 1.0～5.0, chlorhexidine acetate 0.05～0.1, filmogen 2～3, transdermal enhancer 5～15, adrenalin hydrochloride 0.0005～0.001, ethanol 45～55, distilled water 30～50.
The surface anesthesia film that adopts compound method of the present invention to make has reduced narcotic content, has improved anaesthetic effect, clinical cosmetic surgery 336 examples that are used for, double-fold eyelid operation 60 examples wherein, profiling eyelid line 240 examples, lip tattooing line 12 examples, eyebrow tattooing 24 examples, the proof anaesthetic effect is good, easy and simple to handle, and consumption is little, cost is low, and skin is had no adverse reaction.
Embodiment one:
PVA-1750 2.7g is added in the 30ml distilled water, and abundant swelling post-heating to 80 ℃ dissolves about postcooling to 60 ℃ fully, get colloid solution, in addition with propylene glycol 10ml, tetracaine hydrochloride 2.5g, chlorhexidine acetate 0.1g, adrenalin hydrochloride 1mg, be dissolved in 60ml 80% alcoholic solution successively, behind the mix homogeneously, under agitation be added in the colloid solution, mix homogeneously, being cooled to room temperature, promptly to make tetracaine content be 2.5% surface anesthesia film.
Embodiment two:
PVA-1750 2.5g is mixed with the 30ml distilled water, fully swelling post-heating to 80 ℃ dissolving fully is cooled to about 60 ℃, gets colloid solution, in addition with propylene glycol 12ml, lignocaine 5.0g, chlorhexidine acetate 0.05g, adrenalin hydrochloride 0.5mg, be dissolved in successively in 58ml 75% alcoholic solution, mix homogeneously under agitation is added in the colloid solution, and behind the mix homogeneously, being cooled to room temperature, promptly to make lignocaine content be 5.0% surface anesthesia film.
Claims (2)
1, a kind of preparation method of surface anesthesia film is characterized in that: water soluble polymer filmogen PVA2.5-2.7g is mixed with distilled water 30ml, and fully swelling post-heating dissolving is cooled to 60 ℃ and gets colloid solution (I);
In addition tetracaine hydrochloride 2.5g or lignocaine 5.0g, chlorhexidine acetate 0.05-0.1g, adrenalin hydrochloride 0.0005-0.001g, propylene glycol 5-15ml are dissolved in the 75-80% alcoholic solution, get medicine alcoholic solution (II), under agitation (II) is added in (I), mix homogeneously postcooling to room temperature is made.
2, according to the described preparation method of claim 1, it is characterized in that: during preparation, solution (I) and solution (II) by volume calculate, and its umber ratio is:
(I)∶(II)＝20-30∶70-80
The percentage composition W/V (%) of the various compositions in preparation back is:
Tetracaine hydrochloride 2.5 or lignocaine 5.0, filmogen PVA2.5-2.7, chlorhexidine acetate 0.05-0.1, adrenalin hydrochloride 0.0005-0.001, propylene glycol 5-15, ethanol 45-55, distilled water 30-50.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN93104370A CN1050748C (en) | 1993-04-22 | 1993-04-22 | Production method for surface anesthesia film |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN93104370A CN1050748C (en) | 1993-04-22 | 1993-04-22 | Production method for surface anesthesia film |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1093897A CN1093897A (en) | 1994-10-26 |
| CN1050748C true CN1050748C (en) | 2000-03-29 |
Family
ID=4985164
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN93104370A Expired - Fee Related CN1050748C (en) | 1993-04-22 | 1993-04-22 | Production method for surface anesthesia film |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1050748C (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1069826C (en) * | 1997-04-25 | 2001-08-22 | 浙江省中医院 | Freezing-dried tetracaine hydrochloride powder injection |
| US6299902B1 (en) | 1999-05-19 | 2001-10-09 | The University Of Georgia Research Foundation, Inc. | Enhanced transdermal anesthesia of local anesthetic agents |
| GB0718435D0 (en) | 2007-09-21 | 2007-10-31 | Northern Health And Social Car | Wpund care formulation |
| CN103505791A (en) * | 2012-06-28 | 2014-01-15 | 杨德普 | Transdermal-absorption local-anesthesia painless injection puncture alcohol pad |
| US9463201B2 (en) * | 2014-10-19 | 2016-10-11 | M.G. Therapeutics Ltd | Compositions and methods for the treatment of meibomian gland dysfunction |
| CN104352485A (en) * | 2014-11-12 | 2015-02-18 | 武汉大学 | Tetracaine hydrochloride oral cavity anesthetic liquid and preparation method thereof |
| GB2533827B (en) * | 2015-05-21 | 2016-12-21 | Gateway Devices Ltd | Intravenous access device |
| US11040062B2 (en) | 2016-04-14 | 2021-06-22 | Azura Ophthalmics Ltd. | Selenium disulfide compositions for use in treating meibomian gland dysfunction |
| CN106983740A (en) * | 2017-05-19 | 2017-07-28 | 中山大学孙逸仙纪念医院 | A kind of surface of a wound anesthesia lotion and preparation method thereof |
| CN107252490B (en) * | 2017-07-12 | 2019-12-03 | 云平 | A kind of local anaesthesia drug and preparation method thereof |
| JP7723603B2 (en) | 2019-04-12 | 2025-08-14 | アズーラ オフサルミックス エルティーディー． | Compositions and methods for treating contact lens discomfort |
| CN110090197A (en) * | 2019-04-19 | 2019-08-06 | 广州芮一生物科技有限公司 | A kind of film-formable anesthesia face mask cream |
| CN116585451B (en) * | 2023-01-18 | 2024-01-02 | 中国牧工商集团有限公司 | Lidocaine hydrochloride spray containing antibacterial and antioxidant moringa seed polypeptide for pets and preparation method of lidocaine hydrochloride spray |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01230514A (en) * | 1987-11-25 | 1989-09-14 | Osaka Aerosol Ind Corp | Aerosol type patch external use |
| CN1046281A (en) * | 1990-04-30 | 1990-10-24 | 石光生 | Aerosols for protective film of medicine " Hemostatic-Yantongting " |
-
1993
- 1993-04-22 CN CN93104370A patent/CN1050748C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01230514A (en) * | 1987-11-25 | 1989-09-14 | Osaka Aerosol Ind Corp | Aerosol type patch external use |
| CN1046281A (en) * | 1990-04-30 | 1990-10-24 | 石光生 | Aerosols for protective film of medicine " Hemostatic-Yantongting " |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1093897A (en) | 1994-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1050748C (en) | Production method for surface anesthesia film | |
| KR860001801B1 (en) | Preparation method of topical anti-inflammatory composition | |
| FI101596B (en) | Process for the preparation of stable injectable pharmaceutical mixture of florfenicol | |
| FI110161B (en) | Process for preparing a flexible, bioadhesive composition for local application | |
| CA2356310C (en) | External preparations containing a basic drug | |
| AU625075B2 (en) | Delivery system for pharmaceutical or therapeutic actives | |
| US6685959B1 (en) | Pharmaceutical compositions comprising 2-isoxazoles-8-aminotetralin derivatives | |
| KR20050072459A (en) | Adhesive composition for dermal patch and production process thereof | |
| EP1170006B1 (en) | Drug for alleviating migrane | |
| DK159195B (en) | PROCEDURE FOR PREPARING STABLE INJECTABLE SOLUTIONS OF AN OXYTETRACYCLINCHELATE | |
| EP4125752B1 (en) | Hydrogel compositions and preparation thereof | |
| JP2003128557A (en) | Glucosamine-containing cataplasm | |
| JPS5962518A (en) | External drug for topical application and its preparation | |
| EP2340016B1 (en) | Topical formulation of 3-(2,2,2-trimethylhydrazinium) propionate dihydrate | |
| EP1938820B1 (en) | External liquid preparation containing indomethacin | |
| CN104173321A (en) | Preparation method of medicinal composition administrated as external patch and having inflammation eliminating and pain easing activity, and composition obtained therethrough | |
| CN1194697C (en) | Concentrated clear solution containing macrolides drug for intraveenous injection after being dilnted | |
| CA2570599A1 (en) | Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same | |
| JP2006036687A (en) | Tramadol-containing medicinal composition for external use | |
| US20080182907A1 (en) | External pharmaceutical composition containing tramadol | |
| CN120285271A (en) | A hemostatic composition based on chitosan and its application | |
| UA150218U (en) | Hydrogel dressing with lidocaine hydrochloride for the treatment of wound processes in surgical practice | |
| CN119405628A (en) | A bio-based high-viscosity gel patch matrix and its preparation method and application | |
| CN1206999C (en) | Spreader cong. compound Triamcinolone acetate, and its prepn. method | |
| JPS5869248A (en) | External alcohol gel composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |